Pulmonary Tuberculosis
📧 Sign up to get email alerts when something new happens for Pulmonary Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis [Phase 2]
A Phase 2 study is assessing bactericidal activity and safety of adding nicotinamide to bedaquiline, pretomanid, and linezolid for drug-susc…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis [Phase 2]
This is a Phase 2 clinical trial update for TBD09 in combination with other drugs for drug-susceptible pulmonary tuberculosis, and the study…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis [Phase 2]
Phase 2 clinical trial update describing novel regimens being studied for pulmonary tuberculosis; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
A clinical trial update evaluating blood TB DNA as a biomarker to monitor tuberculosis treatment.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis
This ClinicalTrials.gov entry describes a study evaluating the effect of Vitamin D on immune response in pulmonary tuberculosis, with or wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB [Phase 2]
Phase 2 clinical trial update for ID93 + GLA-SE vaccination in participants with rifampicin-susceptible pulmonary tuberculosis. The study is…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Shortened Regimen for Drug-susceptible TB in Children [Phase 3]
A Phase 3 trial in children is testing a shortened regimen for drug-susceptible tuberculosis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
A clinical trial is evaluating the PET tracer 18F-FAPI-74 for imaging in patients with pulmonary tuberculosis. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT [Phase 2]
This clinical trial update describes a Phase 2 randomized study comparing AI-optimized pyrazinamide-hydroxychloroquine to the standard RIPE …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Clinic-based Versus Hotspot-focused Active TB Case Finding [NA]
Clinical trial update indicating a Johns Hopkins study comparing clinic-based versus hotspot-focused active TB case finding is currently rec…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB [Phase 2]
This Phase 2 clinical trial compares an ultra-short course regimen of bedaquiline, clofazimine, pyrazinamide, and delamanid against standard…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia [NA]
This clinical trial update describes a study evaluating whether a peer-led educational intervention improves treatment outcomes among adults…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis [Phase 3]
This clinical trial update reports that a Phase 3 study evaluating regimens containing Quabodepistat for drug-resistant pulmonary tuberculos…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) [Phase 2]
Phase 2 clinical trial evaluating atorvastatin in pulmonary tuberculosis as a population pharmacokinetics/pharmacodynamics sub-study; curren…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Pragmatic Optimized Rifampicin Trial [Phase 3]
This update highlights a Phase 3 pragmatic trial evaluating optimized rifampicin regimens for pulmonary tuberculosis, which is currently rec…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis [Phase 2]
A Phase 2 clinical trial is evaluating the safety, tolerability, and early bactericidal activity of RESP30TB in pulmonary tuberculosis. The …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Digital Health Intervention to Improve TPT Uptake [NA]
A clinical trial update describes a digital health intervention aimed at improving uptake of tuberculosis preventive therapy in pulmonary tu…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting [NA]
A clinical trial update indicating a study is recruiting to evaluate the safety and efficacy of ear acupuncture for nausea and vomiting rela…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort [Phase 3]
Phase 3 trial update evaluating a shorter, all-oral, precision treatment regimen for rifampicin-resistant tuberculosis in a Chinese cohort; …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A PAN-USR TB Multi-Center Trial [Phase 3]
A Phase 3 multicenter clinical trial for pulmonary tuberculosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: PanACEA - STEP2C -01 [Phase 2]
Phase 2 trial STEP2C-01 by PanACEA is currently recruiting for Pulmonary Tuberculosis and Other Specified Pulmonary Tuberculosis.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: ATORvastatin in Pulmonary TUBerculosis [Phase 2]
Phase 2 clinical trial testing atorvastatin as an adjunct therapy in pulmonary tuberculosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis [NA]
Clinical trial update for I-FALMIN albumin supplement in patients with pulmonary tuberculosis and hypoalbuminemia. The study is currently ac…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Short-course Regimens for the Treatment of Pulmonary Tuberculosis [Phase 2, Phase 3]
ClinicalTrials.gov update on Phase 2 and Phase 3 trials evaluating short-course regimens for pulmonary tuberculosis and latent tuberculosis …
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya
A clinical trial evaluating PATHFAST-LAM as a treatment-monitoring tool for tuberculosis in Kenya, with status not yet recruiting.